DE60207234D1 - Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit - Google Patents

Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit

Info

Publication number
DE60207234D1
DE60207234D1 DE60207234T DE60207234T DE60207234D1 DE 60207234 D1 DE60207234 D1 DE 60207234D1 DE 60207234 T DE60207234 T DE 60207234T DE 60207234 T DE60207234 T DE 60207234T DE 60207234 D1 DE60207234 D1 DE 60207234D1
Authority
DE
Germany
Prior art keywords
composition
shilajit
shilajite
cleaned
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60207234T
Other languages
English (en)
Other versions
DE60207234T2 (de
Inventor
Shibnath Ghosal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indian Herbs Research & Supply Co Ltd Uttar
Indian Herbs Res & Supply Co L
Natreon Inc
Original Assignee
Indian Herbs Research & Supply Co Ltd Uttar
Indian Herbs Res & Supply Co L
Natreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indian Herbs Research & Supply Co Ltd Uttar, Indian Herbs Res & Supply Co L, Natreon Inc filed Critical Indian Herbs Research & Supply Co Ltd Uttar
Publication of DE60207234D1 publication Critical patent/DE60207234D1/de
Application granted granted Critical
Publication of DE60207234T2 publication Critical patent/DE60207234T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60207234T 2001-05-18 2002-05-03 Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit Expired - Lifetime DE60207234T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/860,890 US6440436B1 (en) 2001-05-18 2001-05-18 Process for preparing purified shilajit composition from native shilajit
US860890 2001-05-18
PCT/US2002/014259 WO2002094984A2 (en) 2001-05-18 2002-05-03 Process for preparing purified shilajit composition from native shilajit

Publications (2)

Publication Number Publication Date
DE60207234D1 true DE60207234D1 (de) 2005-12-15
DE60207234T2 DE60207234T2 (de) 2006-08-03

Family

ID=25334290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60207234T Expired - Lifetime DE60207234T2 (de) 2001-05-18 2002-05-03 Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit

Country Status (7)

Country Link
US (2) US6440436B1 (de)
EP (1) EP1387614B1 (de)
AT (1) ATE308890T1 (de)
AU (1) AU2002311886A1 (de)
DE (1) DE60207234T2 (de)
ES (1) ES2252467T3 (de)
WO (1) WO2002094984A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440436B1 (en) * 2001-05-18 2002-08-27 Natreon Inc. Process for preparing purified shilajit composition from native shilajit
US6558712B1 (en) * 2001-09-21 2003-05-06 Natreon Inc. Delivery system for pharmaceutical, nutritional and cosmetic ingredients
US20050085454A1 (en) * 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
EP1750739A4 (de) * 2004-04-14 2010-05-05 Natreon Inc Mit sauerstoff angereicherte dibenzo-alpha-pyron-chromoproteine
US20050233942A1 (en) * 2004-04-14 2005-10-20 Shibnath Ghosal Oxygenated dibenzo-alpha-pyrone chromoproteins
US20050282781A1 (en) * 2004-06-18 2005-12-22 Shibnath Ghosal Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
US7250181B2 (en) * 2005-01-19 2007-07-31 Natreon, Inc. Polyherbal compositions and methods for treating viral infections
CN100408653C (zh) * 2005-03-11 2008-08-06 吉林农业大学 土壤生物活化剂
US8475776B2 (en) 2005-04-28 2013-07-02 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
KR100801057B1 (ko) * 2006-07-18 2008-02-04 삼성전자주식회사 컬러 보정 블럭을 구비하는 ｃｍｏｓ 이미지 센서 및 그이미지 센싱 방법
US8894993B2 (en) * 2006-08-04 2014-11-25 Natreon Inc. Mitochondria-targeted antioxidants
CL2009001956A1 (es) * 2009-10-09 2010-06-04 Neuroinnovation Spa Composicion nutracéutica que comprende extracto de shilajit (250-500 mg), acido folico (200-500 ug), vitamina b6(20-40 ug), vitamina b12 (4-8 ug) y excipientes aceptables; metodo de fabricacion; y su uso para prevenir o tratar la enfermedad de alzheimer.
SG191297A1 (en) 2010-12-23 2013-07-31 Amazentis Sa Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
US20120213756A1 (en) * 2011-02-21 2012-08-23 Rosemary Petralia Nutraceutical beverage
EP4233858A1 (de) 2012-06-27 2023-08-30 Amazentis SA Autophagieverbesserung oder -verlängerung durch verabreichung von urolithinen oder vorläufern davon
WO2015157465A1 (en) * 2014-04-08 2015-10-15 Vandecar Christopher Plant and animal extracts and related methods
US10183047B2 (en) 2014-05-21 2019-01-22 Natreon, Inc. Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
WO2016054433A1 (en) 2014-10-02 2016-04-07 Natreon, Inc. Promoting muscle building and repair and treating disorders related to collagen and pertinent proteins by using shilajit
JP2017007951A (ja) * 2015-06-17 2017-01-12 公立大学法人岡山県立大学 ウロリチンを含有する光老化抑制剤
JP2017014154A (ja) * 2015-07-01 2017-01-19 公立大学法人岡山県立大学 ウロリチン類を含有するヒアルロン酸産生促進剤
JP6799767B2 (ja) * 2015-07-07 2020-12-16 公立大学法人岡山県立大学 ウロリチン類を含有するメラニン産生抑制剤
JP2017031108A (ja) * 2015-08-04 2017-02-09 公立大学法人岡山県立大学 ウロリチン類を含有する、抗しわ剤、コラーゲン産生促進剤、ｍｍｐ−１産生抑制剤、及びエラスターゼ活性阻害剤
US11292731B2 (en) 2017-02-02 2022-04-05 Christopher Vandecar Method and apparatus for treating contaminated fluid medium
US11969408B2 (en) 2017-03-08 2024-04-30 Amazentis Sa Method for improving mitophagy in subjects
US20180256471A1 (en) * 2017-03-08 2018-09-13 Amazentis Sa Skin Treatment Methods
KR101844849B1 (ko) 2017-07-27 2018-04-04 주식회사 제니버 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그 제조 방법
WO2020005215A1 (en) * 2018-06-26 2020-01-02 Natreon, Inc. Improvement of blood microperfusion to skin by shilajit
CN109363956B (zh) * 2018-12-29 2022-05-13 广州市科能化妆品科研有限公司 喜来芝提取物的用途和美白水分露及其制备方法
WO2022040321A1 (en) * 2020-08-19 2022-02-24 Natreon, Inc. Protection against coronavirus infection by extracts and extract components

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405613A (en) * 1991-12-11 1995-04-11 Creative Nutrition Canada Corp. Vitamin/mineral composition
US6440436B1 (en) * 2001-05-18 2002-08-27 Natreon Inc. Process for preparing purified shilajit composition from native shilajit

Also Published As

Publication number Publication date
ES2252467T3 (es) 2006-05-16
EP1387614B1 (de) 2005-11-09
EP1387614A2 (de) 2004-02-11
AU2002311886A1 (en) 2002-12-03
US6869612B2 (en) 2005-03-22
ATE308890T1 (de) 2005-11-15
US20030039662A1 (en) 2003-02-27
WO2002094984A2 (en) 2002-11-28
DE60207234T2 (de) 2006-08-03
EP1387614A4 (de) 2004-09-15
US6440436B1 (en) 2002-08-27
WO2002094984A3 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
DE60207234D1 (de) Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit
ATE517607T1 (de) Verfahren zur herstellung von partikeln zur verwendung in einer pharmazeutischen zusammensetzung
BR0306846A (pt) Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido
DE50111495D1 (de) Künstliche sauerstoffträger aus vernetztem modifizierten human- oder schweinehämoglobin, verfahren zu ihrer herstellung aus gereinigtem material, sowie deren verwendung
WO2002090493A3 (en) Δ4-desaturase genes and uses thereof
DE60104457D1 (de) Verfahren zur Herstellung alpha, beta-ungesättigter Carbonsäureester sowie Katalysator zur Verwendung in diesem Verfahren
DE59207907D1 (de) Benzopyranone, verfahren zu ihrer herstellung und verwendung
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
EP1927352A3 (de) Therapeutische Verfahren und Zusammensetzungen mit Isoflavonen
ATE367810T1 (de) Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren
DE60026844D1 (de) Verfahren zur herstellung von 3,3-dimethylbutanal
DE69815750D1 (de) Verfahren zur Herstellung von Ascorbinsäurederivaten
DE50205571D1 (de) Verfahren zur Herstellung von direkt tablettierbaren Beta-Mannit
BR9813811A (pt) "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo"
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
DE60028152D1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher Komplex von Orthokieselsäure und Prozess zur dessen Herstellung
DE50106251D1 (de) Mittel und verfahren zu dauerhaften haarverformung auf basis von 2-mercaptopropionsäureamiden sowie verfahren zu deren herstellung
DE60323356D1 (de) Zusammensetzungen enthaltend protein und fettsäure und verfahren zur herstellung
EP1222919A3 (de) Zusammensetzungen enthaltend Glykoproteinematrix und Wirkstoff und Verfahren zur Herstellung desselben
DE60036758D1 (de) Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze
DE69501183T2 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE248141T1 (de) Verfahren zur herstellung von (r) und (s)- aminocarnitin und deren derivative aus d- und l- aspargin säure
DE60204681D1 (de) Verfahren zur herstellung von 2-[4-(2,2,-dihalocyclopropyl)phenoxy]-alkansäuren und ihre estern
DE60031315D1 (de) Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition